08/07/2025
6:03 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2025
6:15 AM | Amylyx Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/29/2025
10:21 AM | Amylyx Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G | |
07/17/2025
6:44 PM | Amylyx Pharmaceuticals (Subject)
BlackRock, Inc. (Filed by)
| Form SCHEDULE 13G | |
06/25/2025
4:24 PM | Amylyx Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SCHEDULE 13G | |
05/12/2025
8:05 AM | Adage Capital Management, L.P. (Filed by)
Amylyx Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
05/08/2025
6:01 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2025
6:04 AM | Amylyx Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/24/2025
6:05 AM | Amylyx Pharmaceuticals (Filer)
| Form DEF 14A | |
04/24/2025
6:09 AM | Amylyx Pharmaceuticals (Filer)
| Form DEFA14A | |
04/24/2025
6:13 AM | Amylyx Pharmaceuticals (Filer)
| Form ARS | |
Get the Latest News and Ratings for AMLX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Amylyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
04/02/2025
4:22 PM | Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
4:12 PM | Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
4:14 PM | Amylyx Pharmaceuticals (Issuer)
Bedrosian Camille L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
3:52 PM | Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2025
11:15 PM | Amylyx Pharmaceuticals (Filer)
| Form EFFECT | |
03/24/2025
3:15 PM | Amylyx Pharmaceuticals (Issuer)
Zeiher Bernhardt G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
7:32 PM | Amylyx Pharmaceuticals (Issuer)
Bedrosian Camille L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
7:34 PM | Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
7:28 PM | Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
7:28 PM | Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
7:30 PM | Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
3:32 PM | Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
3:32 PM | Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:30 AM | Amylyx Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/04/2025
5:24 AM | Amylyx Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/04/2025
5:07 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2025
5:14 AM | Amylyx Pharmaceuticals (Filer)
| Form POSASR | |
02/26/2025
3:35 PM | Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
3:30 PM | Amylyx Pharmaceuticals (Subject)
Panacea Innovation Ltd (Filed by)
| Form SCHEDULE 13G/A | |
02/06/2025
7:17 PM | Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
3:54 PM | Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
3:55 PM | Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
3:58 PM | Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2025
3:55 PM | Amylyx Pharmaceuticals (Issuer)
MILNE GEORGE M JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:53 PM | Amylyx Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SCHEDULE 13G | |
01/10/2025
4:13 PM | Amylyx Pharmaceuticals (Filer)
| Form 424B5 | |
01/10/2025
4:23 PM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
5:05 AM | Amylyx Pharmaceuticals (Filer)
| Form 424B5 | |
01/08/2025
4:29 PM | Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
4:26 PM | Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Trump set to Boost Social Security Checks by 400%? (Ad) If you're collecting or planning to collect social security...
You should see this presentation about President Trump's Executive Order #14196.
Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse...
But BOOST benefits for millions of retirees by up to 400%.
No wonder the financial times called this new initiative... Click here to see the details because the stakes couldn't be any higher. |
12/30/2024
6:50 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/03/2024
4:21 PM | Amylyx Pharmaceuticals (Issuer)
Bedrosian Camille L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
7:22 AM | Amylyx Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
6:07 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
6:24 PM | Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2024
9:56 AM | Amylyx Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G | |
10/25/2024
4:38 PM | Amylyx Pharmaceuticals (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G | |
10/17/2024
8:12 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2024
5:48 PM | Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
5:50 PM | Amylyx Pharmaceuticals (Issuer)
Bedrosian Camille L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
5:53 PM | Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
5:53 PM | Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2024
4:56 PM | Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
4:39 PM | Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
4:30 PM | Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:55 PM | Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
| Form 4/A | |
09/05/2024
6:26 PM | Amylyx Pharmaceuticals (Issuer)
MILNE GEORGE M JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
5:49 PM | Amylyx Pharmaceuticals (Subject)
TCG Crossover GP II, LLC (Filed by)
| Form SC 13G | |
MarketBeat All Access